[go: up one dir, main page]

AU2016219657A1 - Stable pharmaceutical composition and methods of using same - Google Patents

Stable pharmaceutical composition and methods of using same

Info

Publication number
AU2016219657A1
AU2016219657A1 AU2016219657A AU2016219657A AU2016219657A1 AU 2016219657 A1 AU2016219657 A1 AU 2016219657A1 AU 2016219657 A AU2016219657 A AU 2016219657A AU 2016219657 A AU2016219657 A AU 2016219657A AU 2016219657 A1 AU2016219657 A1 AU 2016219657A1
Authority
AU
Australia
Prior art keywords
methods
same
pharmaceutical composition
stable pharmaceutical
treat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2016219657A
Other versions
AU2016219657B2 (en
Inventor
Mehar Manku
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amarin Pharmaceuticals Ireland Ltd
Original Assignee
Amarin Pharmaceuticals Ireland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2010241571A external-priority patent/AU2010241571B2/en
Priority claimed from AU2014203034A external-priority patent/AU2014203034B2/en
Priority to AU2016219657A priority Critical patent/AU2016219657B2/en
Application filed by Amarin Pharmaceuticals Ireland Ltd filed Critical Amarin Pharmaceuticals Ireland Ltd
Publication of AU2016219657A1 publication Critical patent/AU2016219657A1/en
Application granted granted Critical
Publication of AU2016219657B2 publication Critical patent/AU2016219657B2/en
Priority to AU2018202792A priority patent/AU2018202792B2/en
Priority to AU2019257528A priority patent/AU2019257528B2/en
Priority to AU2022200321A priority patent/AU2022200321B2/en
Priority to AU2024204576A priority patent/AU2024204576A1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases.
AU2016219657A 2009-04-29 2016-08-25 Stable pharmaceutical composition and methods of using same Active AU2016219657B2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
AU2016219657A AU2016219657B2 (en) 2009-04-29 2016-08-25 Stable pharmaceutical composition and methods of using same
AU2018202792A AU2018202792B2 (en) 2009-04-29 2018-04-23 Stable pharmaceutical composition and methods of using same
AU2019257528A AU2019257528B2 (en) 2009-04-29 2019-11-01 Stable pharmaceutical composition and methods of using same
AU2022200321A AU2022200321B2 (en) 2009-04-29 2022-01-19 Stable pharmaceutical composition and methods of using same
AU2024204576A AU2024204576A1 (en) 2009-04-29 2024-07-02 Stable pharmaceutical composition and methods of using same

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US61/173,763 2009-04-29
AU2010241571A AU2010241571B2 (en) 2009-04-29 2010-04-29 Stable pharmaceutical composition and methods of using same
AU2014203034A AU2014203034B2 (en) 2009-04-29 2014-06-04 Stable pharmaceutical composition and methods of using same
AU2016219657A AU2016219657B2 (en) 2009-04-29 2016-08-25 Stable pharmaceutical composition and methods of using same

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2014203034A Division AU2014203034B2 (en) 2009-04-29 2014-06-04 Stable pharmaceutical composition and methods of using same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2018202792A Division AU2018202792B2 (en) 2009-04-29 2018-04-23 Stable pharmaceutical composition and methods of using same

Publications (2)

Publication Number Publication Date
AU2016219657A1 true AU2016219657A1 (en) 2016-09-15
AU2016219657B2 AU2016219657B2 (en) 2018-02-01

Family

ID=56898951

Family Applications (3)

Application Number Title Priority Date Filing Date
AU2016219657A Active AU2016219657B2 (en) 2009-04-29 2016-08-25 Stable pharmaceutical composition and methods of using same
AU2018202792A Ceased AU2018202792B2 (en) 2009-04-29 2018-04-23 Stable pharmaceutical composition and methods of using same
AU2019257528A Ceased AU2019257528B2 (en) 2009-04-29 2019-11-01 Stable pharmaceutical composition and methods of using same

Family Applications After (2)

Application Number Title Priority Date Filing Date
AU2018202792A Ceased AU2018202792B2 (en) 2009-04-29 2018-04-23 Stable pharmaceutical composition and methods of using same
AU2019257528A Ceased AU2019257528B2 (en) 2009-04-29 2019-11-01 Stable pharmaceutical composition and methods of using same

Country Status (1)

Country Link
AU (3) AU2016219657B2 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077828A (en) * 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
DK0843972T3 (en) * 1996-11-20 2002-12-02 Nutricia Nv Food composition containing fats for the treatment of metabolic disorders
US7112609B2 (en) * 1999-06-01 2006-09-26 Drugtech Corporation Nutritional supplements
GB0016452D0 (en) * 2000-07-04 2000-08-23 Kilgowan Limited Vitamin K and essential fatty acids

Also Published As

Publication number Publication date
AU2019257528B2 (en) 2021-11-11
AU2018202792B2 (en) 2019-11-28
AU2019257528A1 (en) 2019-11-28
AU2016219657B2 (en) 2018-02-01
AU2018202792A1 (en) 2018-05-10

Similar Documents

Publication Publication Date Title
PH12016500216A1 (en) Stable pharmaceutical composition and methods of using same
MX2012003555A (en) Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same.
MX2020004099A (en) Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same.
CA2871471C (en) Dna-pk inhibitors
JO2761B1 (en) 1Phenyl-2-Pyridinyl Alkyl Alcohol Derivatives As Phosphodiesterase Inhibitors
TN2011000370A1 (en) Alkylamine-substituted dicyanopyridine and amino acid ester prodrugs thereof
EP3626253A3 (en) Stable formulations of linaclotide
MY158504A (en) Fatty acid niacin conjugates and their uses
IN2012DN02805A (en)
WO2012088266A3 (en) Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
MX2019012939A (en) Linaclotide-containing formulations for oral administration.
WO2011041639A3 (en) Heteroatom containing substituted fatty acids
PH12014501967A1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
UA103930C2 (en) Normal;heading 1;heading 2;heading 3;COMPOUNDS AND COMPOSITION FOR THE TREATMENT OF PARASITIC DISEASES
PH12013502370A1 (en) Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
UA96794C2 (en) Glucocorticoides, method of use thereof, treatment method and pharmaceutical formulation based thereon
WO2011088160A3 (en) Novel cyp17 inhibitors
WO2012099557A3 (en) Fatty acid inhibitors
MX339361B (en) Alternan derivatives.
WO2011014520A3 (en) Compounds and compositions as modulators of gpr119 activity
AU2012345659A8 (en) Acamprosate formulations, methods of using the same, and combinations comprising the same
MX2011006721A (en) Pharmaceutical formulation of nanonised fenofibrate.
WO2012007758A3 (en) Pharmaceutical formulations
AU2016219657A1 (en) Stable pharmaceutical composition and methods of using same
SI2293791T1 (en) Pharmaceutical compositions of entacapone co-micronized with sugar alcohols

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)